Pulmonary hypertension is high blood pressure in the pulmonary arteries in the lungs. With symptoms typical of more common diseases, and a variety of causes, this potentially fatal disease is complex to diagnose and treat.
Pulmonary hypertension can have no known cause, can be genetic, can be caused by drugs or toxins, or can occur because of an underlying disease or issue, including: Congenital heart disease, Left heart disease. Blood clots in the lungs, Lung disease, HIV, Liver disease, Sickle cell disease, Metabolic disorders, Sleep disorders,(i.e. sleep apnea), Connective tissue diseases, such as scleroderma
The Pulmonary Hypertension Program at the University of Michigan Frankel Cardiovascular Center is the largest and most experienced program in the state, and one of the largest in the country. We are a comprehensive, single resource for the care and treatment of patients who live with this challenging disease. In addition, we are accredited as a Center of Comprehensive Care (CCC) through the Pulmonary Hypertension Care Centers (PHCC) program.
Michigan Medicine also serves as the Data Coordinating Center for the Pulmonary Hypertension Breakthrough Initiative, a network of multidisciplinary, collaborative transplant and research centers that distributes stored clinical specimens and relevant data to researchers for use in groundbreaking research to better understand pulmonary arterial hypertension.
Eva Kline Rogers RN, MSN, NP (734)998-5909